Veröffentlichungen Prof. Peters
| 2021 | Benedikt Westphalen C, Bokemeyer C, Büttner R, Fröhling S, Gaidzik VI, Glimm H, Hacker UT, Heinemann V, Illert AL, Keilholz U, Kindler T, Kirschner M, Schilling B, Siveke JT, Schroeder T, Tischler V, Wagner S, Weichert W, Zips D, Loges S; Working Group Molecular Diagnostics and Therapy. Börries M, Peters C, Et al. Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]. Eur J Cancer. 2021 Dec 22:S0959-8049(21)01224-7. doi: 10.1016/j.ejca.2021.11.014. Epub ahead of print. Erratum for: Eur J Cancer. 2020 Aug;135:1-7. PMID: 34953660. |
| Gomez-Auli A, Hillebrand LE, Christen D, Günther SC, Biniossek ML, Peters C, Schilling O, Reinheckel T. The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases. Cell Mol Life Sci. 2021 Jan;78(2):733-755. doi: 10.1007/s00018-020-03528-5. Epub 2020 May 8. PMID: 32385587; PMCID: PMC7873128. | |
| Hoefflin R, Lazarou A, Hess ME, Reiser M, Wehrle J, Metzger P, Frey AV, Becker H, Aumann K, Berner K, Boeker M, Buettner N, Dierks C, Duque-Afonso J, Eisenblaetter M, Erbes T, Fritsch R, Ge IX, Geißler AL, Grabbert M, Heeg S, Heiland DH, Hettmer S, Kayser G, Keller A, Kleiber A, Kutilina A, Mehmed L, Meiss F, Poxleitner P, Rawluk J, Ruf J, Schäfer H, Scherer F, Shoumariyeh K, Tzschach A, Peters C, Brummer T, Werner M, Duyster J, Lassmann S, Miething C, Boerries M, Illert AL, von Bubnoff N. Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Cancers (Basel). 2021 Mar 8;13(5):1151. doi: 10.3390/cancers13051151. Pubmed33800365. | |
| Maruyama K, Yoneda K, Sugita S, Yamamoto Y, Koike M, Peters C, Uchiyama Y, Nishida K. CTLA-2 Alpha Is a Potent Inhibitor of Angiogenesis in Murine Ocular Tissue. Antioxidants (Basel). 2021 Mar 15;10(3):456. doi: 10.3390/antiox10030456. PMID: 33804126; PMCID: PMC8000157. | |
| Kas Steuten, Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, Scott Lovell, Oguz Bolgi, Berati Cerikan, Christopher J. Neufeldt, Mirko Cortese, Ryan K. Muir, John M. Bennett, Ruth Geiss-Friedlander, Christoph Peters, Ralf Bartenschlager, and Matthew Bogyo. Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19. ACS Infect. Dis., February 11, 2021. DOI: 10.1021/acsinfecdis.0c00815 |
|
| 2020 | Fröhling S, Arndt V, Doege D, Albers P, Algül H, Bargou R, Bokemeyer C, Bornhäuser M, Brandts CH, Brossart P, Brümmendorf TH, Döhner H, Hallek M, Heinemann V, Keilholz U, Kindler T, Lordick F, Peters C, Schadendorf D, Zips D, Braun A, Ortmann O, Nettekoven G, Baumann M. Corona-Effekt in der Onkologie. Deutsches Ärzteblatt/Jg. 117/Heft 46/2020 Nov 13. Pdf. |
| Gomez-Auli A, Hillebrand LE, Christen D, Günther SC, Biniossek ML, Peters C, Schilling O, Reinheckel T. The secreted inhibitor of invasive cell growth CREG1 is negatively regulated by cathepsin proteases. Cell Mol Life Sci. 2020 May 8. doi: 10.1007/s00018-020-03528-5. Pubmed32385587 [Epub ahead of print] | |
| Ketterer S, Mitschke J, Ketscher A, Schlimpert M, Reichardt W, Baeuerle N, Hess ME, Metzger P, Boerries M, Peters C, Kammerer B, Brummer T, Steinberg F, Reinheckel T. Cathepsin D deficiency in mammary epithelium transiently stalls breast cancer by interference with mTORC1 signaling. Nat Commun. 2020 Oct 12;11(1):5133. doi: 10.1038/s41467-020-18935-2. Pubmed33046706 | |
| 2019 | Sato T, Yamashina S, Izumi K, Ueno T, Koike M, Ikejima K, Peters C, Watanabe S. Cathepsin L-deficiency enhances liver regeneration after partial hepatectomy. Life Sci. 2019 Mar 15;221:293-300. doi: 10.1016/j.lfs.2019.02.040. Epub 2019 Feb 20. Pubmed30797017 |
| Joos S, Nettelbeck DM, Reil-Held A, Engelmann K, Moosmann A, Eggert A, Hiddemann W, Krause M, Peters C, Schuler M, Schulze-Osthoff K, Serve H, Wick W, Puchta J, Baumann M. German Cancer Consortium (DKTK) - A national consortium for translational cancer research. Mol Oncol. 2019 Mar;13(3):535-542. doi: 10.1002/1878-0261.12430. Epub 2019 Jan 9. Review Pubmed30561127 | |
| Junjun Ni , Zhou Wu , Veronika Stoka , Jie Meng, Yoshinori Hayashi, Christoph Peters, Hong Qing, Vito Turk, Hiroshi Nakanishi. Increased Expression and Altered Subcellular Distribution of Cathepsin B in Microglia Induce Cognitive Impairment Through Oxidative Stress and Inflammatory Response in Mice. Aging Cell, 18 (1), e12856 Feb 2019 DOI: 10.1111/acel.12856 Pubmed30575263 | |
| Köhler M, Ehrenfeld S, Halbach S, Lauinger M, Burk U, Reischmann N, Cheng S, Spohr C, Uhl FM, Köhler N, Ringwald K, Braun S, Peters C, Zeiser R, Reinheckel T, Brummer T. B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model. Oncogene. 2019 Feb;38(8):1324-1339. doi: 10.1038/s41388-018-0663-8. Epub 2019 Jan 18. Pubmed30659267 | |
| 2018 | Hoefflin, R.,Geißler, A.-L., Fritsch, R., Claus, R.,,Wehrle, J., Metzger, P., Reiser, M., Mehmed, L., Fauth, L., Heiland, D.H., Erbes, T., Stock, F.,,Csanadi, A., Miething, C., Weddeling, B., Meiss, F., von Bubnoff, D., Dierks, C., Ge, I., Brass, V., Heeg, S., Schäfer, H., Boeker, M., Rawluk, J., Botzenhart, E.M., Kayser, G., Hettmer, S., Busch, H., Peters, C., Werner, M., Duyster, J., Brummer, T., Boerries, M., Lassmann, S. and von Bubnoff, N. (2018). Personalized clinical decision making through implementation of a Molecular Tumorboard – a German single centre experience. JCO Precision Oncology, DOI: 10.1200/PO.18.00105 JCO Precision Oncology - published online August 16, 2018 |
| 2017 | Hettmer S, Andrieux G, Hochrein J, Kurz P, Rössler J, Lassmann S, Werner M, von Bubnoff N, Peters C, Koscielniak E, Sparber-Sauer M, Niemeyer C, Mentzel T, Busch H, Boerries M. Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26675. Epub 2017 Jun 9. Pubmed28598585 |
| 2016 | Gomez-Auli A, Hillebrand LE, Biniossek ML, Peters C, Reinheckel T, Schilling O. Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers. Biochimie. 2016 Mar;122:88-98. doi: 10.1016/j.biochi.2015.10.009. Epub 2015 Oct 8. Pubmed26455267 |
| Schoffer O, Schülein S, Arand G, ....Peters C, ....Zettl H, Klug SJ.Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011. BMC Cancer. 2016 Dec 5;16(1):936. Pubmed 27919243 | |
| 2015 | Okada R, Wu Z, Zhu A, Ni J, Zhang J, Yoshimine Y, Peters C, Saftig P, Nakanishi H. Cathepsin D deficiency induces oxidative damage in brain pericytes and impairs the blood-brain barrier. Mol Cell Neurosci.2015 Jan;64:51-60. doi: 10.1016/j.mcn.2014.12.002. Epub 2014 Dec 10. PMID: 25496868 |
| 2014 | Akkari L, Gocheva V, Kester JC, Hunter KE, Quick ML, Sevenich L, Wang HW, Peters C, Tang LH, Klimstra DS, Reinheckel T, Joyce JA. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix. Genes Dev. 2014 Oct 1;28(19):2134-50. doi: 10.1101/gad.249599.114. Pubmed25274726 |
| Tamhane T, Arampatzidou M, Gerganova V, Tacke M, Illukkumbura R, Dauth S, Schaschke N, Peters C, Reinheckel T, Brix K. The activity and localization patterns of cathepsins B and X in cells of the mouse gastrointestinal tract differ along its length. Biol Chem. 2014 Oct 1;395(10):1201-19. doi: 10.1515/hsz-2014-0151. PMID: 25205730 | |
| Bengsch F, Buck A, Günther SC, Seiz JR, Tacke M, Pfeifer D, von Elverfeldt D, Sevenich L, Hillebrand LE, Kern U, Sameni M, Peters C, Sloane BF, Reinheckel T. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene. 2014 Sep 4;33(36):4474-84. doi: 10.1038/onc.2013.395. Epub 2013 Sep 30. Pubmed24077280 | |
| Hayashi Y, Koga Y, Zhang X, Peters C, Yanagawa Y, Wu Z, Yokoyama T, Nakanishi H. Autophagy in superficial spinal dorsal horn accelerates the cathepsin B-dependent morphine antinociceptive tolerance. Neuroscience. 2014 Sep 5;275:384-94. doi: 10.1016/j.neuroscience.2014.06.037. Epub 2014 Jun 26. Pubmed24973657 | |
| Butinar M, Prebanda MT, Rajković J, Jerič B, Stoka V, Peters C, Reinheckel T, Krüger A, Turk V, Turk B, Vasiljeva O. Stefin B deficiency reduces tumor growth via sensitization of tumor cells to oxidative stress in a breast cancer model.Oncogene. 2014 Jun 26;33(26):3392-400. doi: 10.1038/onc.2013.314. Epub 2013 Aug 19. Pubmed23955077 | |
| Müller S, Faulhaber A, Sieber C, Pfeifer D, Hochberg T, Gansz M, Deshmukh SD, Dauth S, Brix K, Saftig P, Peters C, Henneke P, Reinheckel T. The endolysosomal cysteine cathepsins L and K are involved in macrophage-mediated clearance of Staphylococcus aureus and the concomitant cytokine induction. FASEB J. 2014 Jan;28(1):162-75. doi: 10.1096/fj.13-232272. Pubmed24036885 | |
| 2013 | Ohkouchi S, Shibata M, Sasaki M, Koike M, Safig P, Peters C, Nagata S, Uchiyama Y. Biogenesis and Proteolytic Processing of Lysosomal DNase II. PLoS One. 2013;8(3):e59148. doi: 10.1371/journal.pone.0059148. Epub 2013 Mar 13. Pubmed 23516607 |
| Koike M, Shibata M, Ezaki J, Peters C, Saftig P, Kominami E, Uchiyama Y. Differences in expression patterns of cathepsin C/dipeptidyl peptidase I in normal, pathological and aged mouse central nervous system. Eur J Neurosci. 2013 Mar;37(5):816-30. doi: 10.1111/ejn.12096. Epub 2012 Dec 20. Pubmed23279039 | |
| 2012 | Unno T, Wakamori M, Koike M, Uchiyama Y, Ishikawa K, Kubota H, Yoshida T, Sasakawa H, Peters C, Mizusawa H, Watase K. Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17693-8. doi: 10.1073/pnas.1212786109. Pubmed23054835 |
| Schurigt U, Eilenstein R, Gajda M, Leipner C, Sevenich L, Reinheckel T, Peters C, Wiederanders B, Bräuer R. Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment. Inflamm Res. Sep;61(9):1021-9. Pubmed22674323 | |
| Sun L, Wu Z, Hayashi Y, Peters C, Tsuda M, Inoue K, Nakanishi H. Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain. J Neurosci. 2012 Aug 15;32(33):11330-42. Pubmed22895716 | |
| Lu WD, Funkelstein L, Toneff T, Reinheckel T, Peters C, Hook V. Cathepsin H Functions as an Aminopeptidase in Secretory Vesicles for Production of Enkephalin and Galanin Peptide Neurotransmitters. J Neurochem. 2012 Aug;122(3):512-22. doi: 10.1111/j.1471-4159.2012.07788.x. Pubmed22582844 | |
| Reinheckel T, Peters C, Krüger A, Turk B, Vasiljeva O. Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target. Front Pharmacol. 2012;3:133. Epub 2012 Jul 11. Pubmed22798952 | |
| Funkelstein L, Lu WD, Koch B, Mosier C, Toneff T, Taupenot L, O'Connor DT, Reinheckel T, Peters C, Hook V. Human cathepsin V protease participates in the production of enkephalin and NPY neurotransmitters. J Biol Chem. 2012May 4;287(19):15232-41. Pubmed22393040 | |
| 2011 | Sun J, Sukhova GK, Zhang J, Chen H, Sjöberg S, Libby P, Xiang M, Wang J, Peters C, Reinheckel T, Shi GP. Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2500-8. PubMed21868704 |
| Bühling F, Kouadio M, Chwieralski CE, Kern U, Hohlfeld JM, Klemm N, Friedrichs N, Roth W, Deussing JM, Peters C, Reinheckel T. Gene targeting of the cysteine peptidase cathepsin h impairs lung surfactant in mice. PLoS One. 2011;6(10):e26247. Epub 2011 Oct 12. PubMed22022579 | |
| Czibere L, Baur LA, Wittmann A, Gemmeke K, Steiner A, Weber P, Pütz B, Ahmad N, Bunck M, Graf C, Widner R, Kühne C, Panhuysen M, Hambsch B, Rieder G, Reinheckel T, Peters C, Holsboer F, Landgraf R, Deussing JM. Profiling trait anxiety: transcriptome analysis reveals cathepsin B (Ctsb) as a novel candidate gene for emotionality in mice. PLoS One. 2011;6(8):e23604. Epub 2011 Aug 29. PubMed21897848 | |
| Mikhaylov G, Mikac U, Magaeva AA, Itin VI, Naiden EP, Psakhye I, Babes L, Reinheckel T, Peters C, Zeiser R, Bogyo M, Turk V, Psakhye SG, Turk B, Vasiljeva O. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment. Nat Nanotechnol. 2011 Aug 7;6(9):594-602.doi:10.1038/nnano. 2011.112. PubMed21822252 | |
| Sevenich L, Werner F, Gajda M, Schurigt U, Sieber C, Müller S, Follo M, Peters C, Reinheckel T. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene. 2011 Jan 6;30(1):54-64. PubMed20818432. | |
| 2010 | Konjar S, Sutton VR, Hoves S, Repnik U, Yagita H, Reinheckel T, Peters C, Turk V, Turk B, Trapani JA, Kopitar-Jerala N. Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L. Immunology. 2010 Oct;131(2):257-67. Pubmed20497254 |
| Sun L, Wu Z, Baba M, Peters C, Uchiyama Y, Nakanishi H. Cathepsin B-dependent motor neuron death after nerve injury in the adult mouse. Biochem Biophys Res Commun. 2010 Aug 27;399(3):391-5. Pubmed20673755 | |
| Dennemärker J, Lohmüller T, Müller S, Aguilar SV, Tobin DJ, Peters C, Reinheckel T. Impaired turnover of autophagolysosomes in cathepsin L deficiency. Biol Chem. 2010 Aug;391(8):913-22. Pubmed20536383 | |
| Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem. 2010 Aug;391(8):937-45. Pubmed2031543 | |
| D'Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem. 2010 Jul 2;285(27):20514-9. Pubmed20435891 | |
| Sevenich L, Hagemann S, Stoeckle C, Tolosa E, Peters C, Reinheckel T. Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice. Biochimie. 2010 Nov;92(11):1674-80. Pubmed20347002 | |
| Shimada N, Ohno-Matsui K, Iseki S, Koike M, Uchiyama Y, Wang J, Yoshida T, Sato T, Peters C, Mochizuki M, Morita I. Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization. Am J Pathol. 2010 May;176(5):2571-80. Epub 2010 Mar 19. Pubmed20304958 | |
| Matthews SP, Werber I, Deussing J, Peters C, Reinheckel T, Watts C. Distinct protease requirements for antigen presentation in vitro and in vivo. J Immunol. 2010 Mar 1;184(5):2423-31. Pubmed20164435 | |
| Wartmann T, Mayerle J, Kähne T, Sahin-Tóth M, Ruthenbürger M, Matthias R, Kruse A, Reinheckel T, Peters C, Weiss FU, Sendler M, Lippert H, Schulz HU, Aghdassi A, Dummer A, Teller S, Halangk W, Lerch MM. Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice. Gastroenterology. 2010 Feb;138(2):726-37. Pubmed19900452 | |
| Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Müller S, Vasiljeva O, Schwinde A, Klemm N, Deussing J, Peters C, Reinheckel T. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2497-502. Pubmed20133781 | |
| Minokadeh A, Funkelstein L, Toneff T, Hwang SR, Beinfeld M, Reinheckel T, Peters C, Zadina J, Hook V. Cathepsin L participates in dynorphin production in brain cortex, illustrated by protease gene knockout and expression. Mol Cell Neurosci. 2010 Jan;43(1):98-107. Pubmed19837164 | |
| Terada K, Yamada J, Hayashi Y, Wu Z, Uchiyama Y, Peters C, Nakanishi H. Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia. 2010 Jan 1;58(1):114-24. Pubmed19544382 | |
| Dennemärker J, Lohmüller T, Mayerle J, Tacke M, Lerch MM, Coussens LM, Peters C, Reinheckel T. Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.Oncogene. 2010 Mar 18;29(11):1611-21. Pubmed20023699 | |
| 2009 | Xiao K, Jehle F, Peters C, Reinheckel T, Schirmer RH, Dandekar T. CA/C1 peptidases of the malaria parasites Plasmodium falciparum and P. berghei and their mammalian hosts--a bioinformatical analysis. Biol Chem. 2009 Nov;390(11):1185-97. Pubmed19663681 |
| Sugita S, Horie S, Nakamura O, Maruyama K, Takase H, Usui Y, Takeuchi M, Ishidoh K, Koike M, Uchiyama Y, Peters C, Yamamoto Y, Mochizuki M. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions. J Immunol. 2009 Oct 15;183(8):5013-22. Pubmed19801522 | |
| Beinfeld MC, Funkelstein L, Foulon T, Cadel S, Kitagawa K, Toneff T, Reinheckel T, Peters C, Hook V. Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies. Peptides. 2009 Oct;30(10):1882-91. Pubmed19589362 | |
| Hook VY, Kindy M, Reinheckel T, Peters C, Hook G. Genetic cathepsin B deficiency reduces beta-amyloid in transgenic mice expressing human wild-type amyloid precursor protein. Biochem Biophys Res Commun. 2009 Aug 21;386(2):284-8. Pubmed19501042 | |
| Vreemann A, Qu H, Mayer K, Andersen LB, Stefana MI, Wehner S, Lysson M, Farcas AM, Peters C, Reinheckel T, Kalff J, Brix K. Cathepsin B release from rodent intestine mucosa due to mechanical injury results in extracellular matrix damage in early post-traumatic phases.Biol Chem. 2009 May-Jun;390(5-6):481-92. Pubmed19335208 | |
| Wilson SR, Peters C, Saftig P, Brömme D. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem. 2009 Jan 23;284(4):2584-92. Pubmed19028686 | |
| 2008 | Funkelstein L, Toneff T, Mosier C, Hwang SR, Beuschlein F, Lichtenauer UD, Reinheckel T, Peters C, Hook V. Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, {beta}-Endorphin, and {alpha}-MSH, Illustrated by Protease Gene Knockout and Expression. J BiolChem. 2008 Dec19; 283(51):356529. Pubmed18849346 |
| Funkelstein L, Toneff T, Hwang SR, Reinheckel T, Peters C, Hook V. Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression. J Neurochem. 2008 Jul;106(1):384-91. Pubmed18410501 | |
| Vasiljeva O, Korovin M, Gajda M, Brodoefel H, Bojic L, Krüger A, Schurigt U, Sevenich L, Turk B, Peters C, Reinheckel T. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene. 2008 Jul 10;27(30):4191-9. Pubmed18345026 | |
| Reinheckel, T., Gocheva, V., Peters, C., Joyce, J.A.: Roles of Cysteine Proteases in Tumor Progression: Analysis of Cysteine Cathepsin Knockout Mice in Cancer Models. In: D. Edwards et al. (eds.): The Cancer Degradome, Springer Science, cap. 15. 2008 / Buchbeitrag | |
| 2007 | Bojic L, Petelin A, Stoka V, Reinheckel T, Peters C, Turk V, Turk B. Cysteine cathepsins are not involved in Fas/CD95 signalling in primary skin fibroblasts. FEBS Lett. 2007 Nov 13;581(27):5185-90. Pubmed1950288 |
| Spira D, Stypmann J, Tobin DJ, Petermann I, Mayer C, Haggemann S, Vasiljeva O, Günther T, Schüle R, Peters C, Reinheckel T. Cell type-specific functions of the lysosomal protease cathepsin L in the heart. J Biol Chem. 2007 Oct 17. Pubmed17942402 | |
| Yamasaki R, Zhang J, Koshiishi I, Sastradipura Suniarti DF, Wu Z, Peters C, Schwake M, Uchiyama Y, Kira J, Saftig P, Utsumi H, Nakanishi H. Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice.Mol Cell Neurosci. 2007 Aug;35(4):573-84. Pubmed17570679 | |
| Kitamoto S, Sukhova GK, Sun J, Yang M, Libby P, Love V, Duramad P, Sun C, Zhang Y, Yang X, Peters C, Shi GP. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation. 2007 Apr 17;115(15):2065-75. Epub 2007 Apr 2. Pubmed17404153 | |
| Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des. 2007;13(4):387-403. Pubmed17311556 | |
| 2006 | Baran K, Ciccone A, Peters C, Yagita H, Bird PI, Villadangos JA, Trapani JA. Cytotoxic T lymphocytes from cathepsin B-deficient mice survive normally in vitro and in vivo after encountering and killing target cells. J Biol Chem. 2006 Oct 13;281(41):30485-91. Pubmed16914553 |
| Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res. 2006 Sep;21(9):1399-408. Pubmed16939398 | |
| Sevenich L, Pennacchio LA, Peters C, Reinheckel T. Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice. Biol Chem. 2006 Jul;387(7):885-91. Pubmed16913838 | |
| Petermann I, Mayer C, Stypmann J, Biniossek ML, Tobin DJ, Engelen MA, Dandekar T, Grune T, Schild L, Peters C, Reinheckel T. Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice. FASEB J. 2006 Jun;20(8):1266-8. Pubmed16636100 | |
| Vasiljeva O, Papazoglou A, Kruger A, Brodoefel H, Korovin M, Deussing J, Augustin N, Nielsen BS, Almholt K, Bogyo M, Peters C, Reinheckel T. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 2006 May 15;66(10):5242-50. Pubmed16707449 | |
| Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 2006 Mar 1;20(5):543-56. Pubmed16481467 | |
| 2005 | Reinheckel T, Hagemann S, Dollwet-Mack S, Martinez E, Lohmuller T, Zlatkovic G, Tobin DJ, Maas-Szabowski N, Peters C. The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. J Cell Sci. 2005 Aug 1;118(Pt 15):3387-95. Pubmed16079282 |
| Henningsson F, Yamamoto K, Saftig P, Reinheckel T, Peters C, Knight SD, Pejler G. A role for cathepsin E in the processing of mast-cell carboxypeptidase A. J Cell Sci. 2005 May 1;118(Pt 9):2035-42. Pubmed15860733 | |
| Urbich C, Heeschen C, Aicher A, Sasaki KI, Bruhl T, Farhadi MR, Vajkoczy P, Hofmann WK, Peters C, Pennacchio LA, Abolmaali ND, Chavakis E, Reinheckel T, Zeiher AM, Dimmeler S. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med. 2005 Feb;11(2):206-13. Pubmed15665831 | |
| 2004 | Hagemann S, Gunther T, Dennemarker J, Lohmuller T, Bromme D, Schule R, Peters C, Reinheckel T. The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles. Eur J Cell Biol. 2004 Dec;83(11-12):775-80. Pubmed15679121 |
| Wille A, Gerber A, Heimburg A, Reisenauer A, Peters C, Saftig P, Reinheckel T, Welte T, Buhling F. Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells. Biol Chem. 2004 Jul;385(7):665-70. Pubmed15318816 | |
| Hook V, Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Troutner K, Toneff T, Bundey R, Logrinova A, Reinheckel T, Peters C, Bogyo M. Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones. Biol Chem. 2004 Jun;385(6):473-80. Pubmed15255178 | |
| Faller D, Reinheckel T, Wenzler D, Hagemann S, Xiao K, Honerkamp J, Peters C, Dandekar T, Timmer J. An open source protein gel documentation system for proteome analyses. J Chem Inf Comput Sci. 2004 Jan-Feb;44(1):168-9. Pubmed14741024 | |
| 2003 | Houseweart MK, Pennacchio LA, Vilaythong A, Peters C, Noebels JL, Myers RM. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J Neurobiol. 2003 Sep 15;56(4):315-27. |
| Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Toneff T, Bundey R, Miller R, Schilling B, Petermann I, Dehnert J, Logvinova A, Goldsmith P, Neveu JM, Lane WS, Gibson B, Reinheckel T, Peters C, Bogyo M, Hook V. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9590-5. Pubmed12869695 | |
| Lohmuller T, Wenzler D, Hagemann S, Kiess W, Peters C, Dandekar T, Reinheckel T. Toward computer-based cleavage site prediction of cysteine endopeptidases. Biol Chem. 2003 Jun;384(6):899-909. Pubmed12887057 | |
| 2002 | Nishimura F, Naruishi H, Naruishi K, Yamada T, Sasaki J, Peters C, Uchiyama Y, Murayama Y. Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice. Am J Pathol 2002 Dec;161(6):2047-52. Pubmed12466121 |
| Ebert DH, Deussing J, Peters C, Dermody TS. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 2002 Jul 5;277(27):24609-17. Pubmed11986312 | |
| Honey K, Nakagawa T, Peters C, Rudensky A. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J Exp Med 2002 May 20;195(10):1349-58. Pubmed12021314 | |
| Tobin DJ, Foitzik K, Reinheckel T, Mecklenburg L, Botchkarev VA, Peters C, Paus R. The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol 2002 May;160(5):1807-21. Pubmed12000732 | |
| Nishioku T, Hashimoto K, Yamashita K, Liou SY, Kagamiishi Y, Maegawa H, Katsube N, Peters C, von Figura K, Saftig P, Katunuma N, Yamamoto K, Nakanishi H. Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J Biol Chem 2002 Feb 15;277(7):4816-22. Pubmed11719510 | |
| Deussing J, Kouadio M, Rehman S, Werber I, Schwinde A, Peters C. Identification and characterization of a dense cluster of placenta-specific cysteine peptidase genes and related genes on mouse chromosome 13. Genomics 2002 Feb;79(2):225-40. Pubmed11829493 | |
| Zwad O, Kubler B, Roth W, Scharf JG, Saftig P, Peters C, Braulke T. Decreased intracellular degradation of insulin-like growth factor binding protein-3 in cathepsin L-deficient fibroblasts. FEBS Lett 2002 510(3), 211-215. Pubmed11801256 | |
| 2001 | Nishioku T, Hashimoto K, Yamashita K, Liou SY, Kagamiishi Y, Maegawa H, Katsube N, Peters C, von Figura K, Saftig P, Katunuma N, Yamamoto K, Nakanishi H. Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J Biol Chem 2001 Nov 21. Pubmed1171951 |
| Honey K, Duff M, Beers C, Brissette WH, Elliott EA, Peters C, Maric M, Cresswell P, Rudensky A. (2001) Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes. J Biol Chem 276(25), 22573-8. Pubmed11306582 | |
| Nakanishi H, Zhang J, Koike M, Nishioku T, Okamoto Y, Kominami E, von Figura K, Peters C, Yamamoto K, Saftig P, Uchiyama Y. (2001) Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci 21(19), 7526-33. Pubmed11567042 | |
| Reinheckel T, Deussing J, Roth W, Peters C. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 382(5), 735-41. Pubmed11517926 | |
| 2000 | Deussing, J., von Olshausen, I., and Peters, C. (2000). Murine and Human Cathepsin Z: cDNA-cloning, characterization of the genes and chromosomal localization. Biochim. Biophys. Acta 1491, 93-106. Pubmed10760573 |
| Deussing, J., Tisljar, K., Papazoglou, A., and Peters, C. (2000). Mouse Cathepsin F: cDNA cloning, genomic organization and chromosomal assignment of the gene. Gene 251(2):165-73. Pubmed10876093 | |
| Guicciardi, M.E., Deussing, J., Miyoshi, H., Bronk, S.F., Svingen, P.A., Peters, C., Kaufmann, S.H., and Gores, G.J. (2000) Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106, 1127-37. Pubmed11067865 | |
| Halangk, W., Lerch, M.M., Brandt-Nedelev, B., Roth, W., Ruthenbuerger, M., Reinheckel, T., Domschke, W., Lippert, H., Peters, C., and Deussing, J. (2000). Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 106, 773-81. Pubmed10995788 | |
| Heinrich, M., Wickel, M., Winoto-Morbach, S., Schneider-Brachert, W., Weber, T., Brunner, J., Saftig, P., Peters, C., Krönke, M., and Schütze, S. (2000). Ceramide as an activator lipid of cathepsin D (Review). Adv. Exp. Med. Biol. 477, 305-15. Pubmed10849758 | |
| Hrabe de Angelis, M.H., Flaswinkel, H., Fuchs, H., Rathkolb, B., Soewarto, D., Marschall, S., Heffner, S., Pargent, W., Wuensch, K., Jung, M., Reis, A., Richter, T., Alessandrini, F., Jakob, T., Fuchs, E., Kolb, H., Kremmer, E., Schaeble, K., Rollinski, B., Roscher, A., Peters, C., Meitinger, T., Strom, T., Steckler, T., Holsboer, F., Klopstock T. Gekeler, F., Schindewolf, C., Jung, T., Avraham, K., Behrendt, H., Ring, J., Zimmer, A., Schughart, K., Pfeffer, K., Wolf, E., and Balling, R. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 25, 444-7. Pubmed10932192 | |
| Koike, M., Nakanishi, H., Saftig, P., Ezaki, J., Isahara, K., Ohsawa, Y., Schulz-Schaeffer, W., Watanabe, T., Waguri, S., Kametaka, S., Shibata, M., Yamamoto, K., Kominami, E., Peters, C., von Figura, K., and Uchiyama, Y. (2000). Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J. Neurosci. 20, 6898-906. Pubmed10995834 | |
| Moin, K., Demchik, L., Mai, J., Deussing, J., Peters, C., and Sloane, B.F. (2000). Observing proteases in living cells (Review). Adv. Exp. Med. Biol. 477, 391-401. Pubmed10849765 | |
| Roth, W., Deussing, J., Botchkarev, V.A., Pauly-Evers, M., Saftig, P., Hafner, A., Schmidt, P., Schmahl, W., Scherer, J., Anton-Lamprecht, I., von Figura, K., Paus, R., and Peters, C. (2000). Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J., 14, 2075-86. Pubmed11023992 | |
| Tatnell, P.J., Cook, M., Peters, C., and Kay, J. (2000) Molecular organization, expression and chromosomal localization of the mouse pronapsin gene. Eur. J. Biochem. 267, 6921-30. Pubmed11082205 | |
| Botchkareva, N.V., Botchkarev, V.A., Welker, P., Airaksinen, M., Roth, W., Suvanto, P., Müller-Röver, S., Hadshiew, I.M., Peters, C., and Paus, R. (2000). New roles for glial cell line-derived neurotrophic factor and neurturin: involvement in hair cycle control. Am. J. Pathol. 156, 1041-53. Pubmed10702420 | |
| 1999 | Heinrich, M., Wickel, M., Schneider-Brachert, W., Sandberg, C., Gahr, J., Schwandner, R., Weber, T., Brunner, J., Saftig, P., Peters, C., Brunner, J., Krönke, M., and Schütze, S. (1999). Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18, 5252-63. Pubmed10508159 |
| Tisljar, K., Deussing, J., and Peters, C. (1999). Cathepsin J, a novel murine cysteine protease of the papain family with a placenta-restricted expression. FEBS Lett. 459, 299-304. Pubmed10526153 | |
| Botchkarev, V.A., Botchkareva, N.V., Roth, W., Nakamura, M., Chen, L.-H., Herzog, W., Lindner, G., McMahon, J.A., Peters, C., Lauster, R., McMahon, A.P., and Paus, R. (1999). Noggin is a mesenchymally derived stimulator of hair follicle induction. Nat. Cell Biol. 1, 158-64. Pubmed10559902 | |
| Villadangos, J.A., Bryant, R.A., Deussing, J., Driessen, C., Lennon-Dumenil, A.M., Riese, R.J., Roth, W., Saftig, P., Shi, G.P., Chapman, H.A., Peters, C., and Ploegh, H.L. (1999). Proteases involved in MHC class II antigen presentation. (Review). Immunol. Rev. 172, 109-20. Pubmed10631941 | |
| 1998 | Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H.L., and Villadangos, J.A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA 95, 4516-21. Pubmed9539769 |
| Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A. (1998). Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280, 450-3. Pubmed9545226 | |
| Tatnell, P.J., Roth, W., Deussing, J., Peters, C., and Kay, J. (1998). Mouse procathepsin E gene: molecular organisation and chromosomal localisation. Biochim. Biophys. Acta 1398(1), 57-66. Pubmed9602058 | |
| Wu, G. S., Saftig, P., Peters, C., and El-Deiry, W. S. (1998). Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16, 2177-83. Pubmed9619826 | |
| 1997 | Deussing, J., Pauly-Evers, M., Roth, W., Saftig, P., and Peters, C. (1997). Manipulating the Mouse Genome (Review). Futura 12, 162-71 |
| Deussing, J., Roth, W., Rommerskirch, W., Wiederanders, B., von Figura, K., and Peters, C. (1997). The genes of the lysosomal cysteine proteinases cathepsin B, H, L, and S map to different mouse chromosomes. Mamm. Genome 8, 241-5. Pubmed9096102 | |
| Saftig, P., Hartmann, D., Lüllmann-Rauch, R., Wolff, J., Evers, M., Köster, A., Hetman, M., von Figura, K., and Peters, C. (1997). Mice deficient in lysosomal acid phosphatase develop lysosomal storage in the kidney and central nervous system. J. Biol. Chem. 272, 18628-35. Pubmed9228031 | |
| Villadangos, J.A., Riese, R.J., Peters, C., Chapman, H.A., and Ploegh, H.L. (1997). Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186, 549-60. Pubmed9254653 | |
| 1996 | Braulke, T., Claussen, M., Saftig, P., Wendland, M., Neifer, K., Schmidt, B., Zapf, J., von Figura, K., and Peters, C. (1996). Proteolysis of IGFBPs by cathepsin D in vitro and in cathepsin D-deficient mice (Review). Prog. Growth Factor Res. 6, 265-71. Pubmed8817669 |
| Evers, M., Saftig, P., Schmidt, P., Hafner, A., McLoghlin, D.B., Schmahl, W., Hess, B., von Figura, K., and Peters, C. (1996). Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI. Proc. Natl. Acad. Sci. USA 93, 8214-9. Pubmed8710849 | |
| Hess, B., Saftig, P., Hartmann, D., Coenen, R., Lüllmann-Rauch, R., Goebel, H. H., Evers, M., von Figura, K., D´Hooge, R., Nagels, G., DeDeyn, P., Peters, C., and Gieselmann, V. (1996). Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci. USA 93, 14821-6. Pubmed8962139 | |
| Isbrandt, D., Hopwood, J.J., von Figura, K., and Peters, C. (1996). Two novel frameshift mutations causing premature stop codons in a patient with the severe form of Maroteaux-Lamy syndrome. Hum. Mutat. 7, 361-3. Pubmed8723688 | |
| Litjens, T., Brooks, D.A., Peters, C., Gibson, G.J., and Hopwood, J.J. (1996). Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients. Am. J. Hum. Genet. 58, 1127-34. Pubmed8651289 | |
| Saftig, P., Peters, C., von Figura, K., Craessaerts, K., van Leuven, F., and De Strooper, B. (1996). Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J. Biol. Chem. 271, 27241-4. Pubmed8910296 | |
| 1995 | Brooks, D.A., Robertson, D.A., Bindloss, C., Litjens, T., Anson, D.S., Peters, C., Morris, C.P., and Hopwood, J.J. (1995). Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein. Biochem. J. 307, 457-463. Pubmed7733883 |
| Saftig, P., Hetman, M., Schmahl, W., Weber, K., Heine, L., Mossmann, H., Köster, A., Hess, B., Evers, M., von Figura, K., and Peters, C. (1995). Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J. 14, 3599-608. Pubmed7641679 | |
| 1994 | Arlt, G., Brooks, D.A., Isbrandt, D., Hopwood, J.J., Bielicki, J., Bradford, T.M., Bindloss-Petherbridge, C.A., von Figura, K., and Peters, C. (1994). Juvenile form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). A C-terminal extension causes instability but increases catalytic efficiency of arylsulfatase B. J. Biol. Chem. 269, 9638-43. Pubmed8144552 |
| von Figura, K., Hille-Rehfeld, A., Lehmann, L., Peters, C., and Prill, V. Signal-Mediated Targeting of Lysosomal Membrane Glycoproteins (Review). 44. Colloquium Mosbach 1993, DNA Replication and the Cell Cycle, Springer-Verlag Berlin Heidelberg pp. 33-44 | |
| Hetman, M., Perschl, A., Saftig, P., von Figura, K., and Peters, C. (1994). Mouse cathepsin D gene: molecular organization, characterization of the promoter, and chromosomal localization. DNA Cell Biol. 13, 419-27. Pubmed8011168 | |
| Isbrandt, D., Arlt, G., Brooks, D.A., Hopwood, J.J., von Figura, K., and Peters, C. (1994). Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. Am. J. Hum. Genet. 54, 454-63. Pubmed8116615 | |
| Peters, C., and von Figura, K. (1994). Biogenesis of lysosomal membranes (Review). FEBS Lett. 346, 108-14. Pubmed8206148 | |
| Voskoboeva, E., Isbrandt, D., von Figura, K., Krasnopolskaya, X., and Peters, C. (1994). Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome). Hum. Genet. 93, 259-64. Pubmed8125475 | |
| 1993 | Brömme, D., Bonneau, P.R., Lachance, P., Wiederanders, B., Kirschke, H., Peters, C., Thomas, D.Y., Storer, A.C., and Vernet, T. (1993). Functional expression of human cathepsin S in Saccharomyces cerevisiae: purification and characterization of the recombinant enzyme. J. Biol. Chem. 268, 4832-8.. Pubmed8444861 |
| Köster, A., Saftig, P., Matzner, U., von Figura, K., Peters, C., and Pohlmann, R. (1993). Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins. EMBO J. 12, 5219-23. Pubmed8262064 | |
| Modaressi, S., Rupp, K., von Figura, K., and Peters, C. (1993). Structure of the human arylsulfatase B gene. Biol. Chem. Hoppe Seyler 374, 327-35. Pubmed7687847 | |
| Prill, V., Lehmann, L., von Figura, K., and Peters, C. (1993). The cytoplasmic tail of lysosomal acid phosphatase contains overlapping but distinct signals for basolateral sorting and rapid internalization in polarized MDCK cells. EMBO J. 12, 2181-93. Pubmed8491206 | |
| 1992 | Anson, D.S., Taylor, J.A., Bielicki, J., Harper, G.S., Peters, C., Gibson, G.J., and Hopwood, J.J. (1992). Correction of human mucopolysaccharidosis type VI fibroblasts with recombinant N-acetylgalactosamine- 4-sulphatase. Biochem. J. 284, 789-94. Pubmed1320379 |
| Bresciani, R., Peters, C., and von Figura, K. (1992). Lysosomal acid phosphatase is not involved in the dephosphorylation of mannose 6-phosphate containing lysosomal proteins. Eur. J. Cell Biol. 58, 57-61. Pubmed1353723 | |
| Hille, A., Klumperman, J., Geuze, H.J., Peters, C., Brodsky, F.M., and von Figura, K. (1992). Lysosomal acid phosphatase is internalized via clathrin-coated pits. Eur. J. Cell Biol. 59, 106-15. Pubmed1468434 | |
| Lehmann, L.E., Eberle, W., Krull, S., Prill, V., Schmidt, B., Sander, C., von Figura, K., and Peters, C. (1992). The internalization signal in the cytoplasmic tail of lysosomal acid phosphatase consists of the hexapeptide PGYRHV. EMBO J. 11, 4391-4399. Pubmed1425575 | |
| Litjens, T., Morris, C.P., Robertson, E.F., Peters, C., von Figura, K., and Hopwood, J.J. (1992). An N-acetylgalactosamine- 4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype. Hum. Mutat. 1, 397-402. Pubmed1301949 | |
| Peters, C., Braun, M., Weber, B., Wendland, M., Schmidt, B., Pohlmann, R., Waheed, A. and von Figura, K. (1992). The nineteen amino acid cytoplasmic tail of lysosomal acid phosphatase contains an endocytosis signal necessary and sufficient for targeting to lysosomes (Review). in: Endocytosis. Ed.: P.J. Courtoy. NATO ASI Series, Vol. H 62, Springer-Verlag Berlin Heidelberg. | |
| Wiederanders, B., Brömme, D., Kirschke, H., von Figura, K., Schmidt, B., and Peters, C. (1992). Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S. J. Biol. Chem. 267, 13708-13. Pubmed1377692 | |
| 1991 | Eberle, W., Sander, C., Klaus, W., Schmidt, B., von Figura, K., and Peters, C. (1991). The essential tyrosine of the internalization signal in lysosomal acid phosphatase is part of a beta turn. Cell 67, 1203-9. Pubmed1760845 |
| Peters, C., Rommerskirch, W., Modaressi, S., and von Figura, K. (1991). Restoration of arylsulfatase B activity in human mucopolysaccharidosis- type-VI fibroblasts by retroviral-vector-mediated gene transfer. Biochem. J. 276, 499-504. Pubmed1904721 | |
| Rommerskirch, W., Fluharty, A.L., Peters, C., von Figura, K., and Gieselmann, V. (1991). Restoration of arylsulfatase A activity in human-metachromatic- leukodystrophy fibroblasts via retroviral-vector-mediated gene transfer. Biochem. J. 280, 459-61. Pubmed1684103 | |
| Wicker, G., Prill, V., Brooks, D., Gibson, G., Hopwood, J., von Figura, K., and Peters, C. (1991). Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B. J. Biol. Chem. 266, 21386-91. Pubmed1718978 | |
| 1990 | Peters, C., Braun, M., Weber, B., Wendland, M., Schmidt, B., Pohlmann, R., Waheed, A., and von Figura, K. (1990). Targeting of a lysosomal membrane protein: a tyrosine-containing endocytosis signal in the cytoplasmic tail of lysosomal acid phosphatase is necessary and sufficient for targeting to lysosomes. EMBO J. 9, 3497-506. Pubmed2209556 |
| Peters, C., Schmidt, B., Rommerskirch, W., Rupp, K., Zühlsdorf, M., Vingron, M., Meyer, H.E., Pohlmann, R., and von Figura, K. (1990). Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J. Biol. Chem. 265, 3374-81. Pubmed2303452 | |
| 1989 | Peters, C., Geier, C., Pohlmann, R., Waheed, A., von Figura, K., Roiko, K., Virkkunen, P., Henttu, P., and Vihko, P. (1989). High degree of homology between primary structure of human lysosomal acid phosphatase and human prostatic acid phosphatase. Biol. Chem. Hoppe Seyler 370, 177-81. Pubmed2706086 |
| Peters, C., Kruse, U., Pollwein, R., Grzeschik, K.H., and Sippel, A.E. (1989). The human lysozyme gene. Sequence organization and chromosomal localization. Eur. J. Biochem. 182, 507-16. Pubmed2546758 | |
| 1988 | Bonifer, C., Hecht, A., Peters, C., and Sippel. A.E. (1988). Rat antibodies as probes for the characterization of progesterone receptor A and B proteins from laying hen oviduct cytosol. Biochim. Biophys. Acta 968, 96-108. Pubmed3337848 |
| 1987 | Peters, C., Sippel, A.E., Vingron, M., and Klempnauer K.H. (1987). Drosophila and vertebrate myb proteins share two conserved regions, one of which functions as a DNA-binding domain. EMBO J. 6, 3085-90. Pubmed3121304 |
| 1981 | Peters, C., Schwermann, J., Schmidt, A., and Buddecke, E. (1981). Phosphate ester groups in proteoglycans from bovine nasal cartilage. Biochim. Biophys. Acta 673, 270-8. Pubmed7225419 |